Navigation Links
Artificial retina receives FDA approval
Date:2/14/2013

The U.S. Food and Drug Administration (FDA) granted market approval to an artificial retina technology today, the first bionic eye to be approved for patients in the United States. The prosthetic technology was developed in part with support from the National Science Foundation (NSF).

The device, called the Argus II Retinal Prosthesis System, transmits images from a small, eye-glass-mounted camera wirelessly to a microelectrode array implanted on a patient's damaged retina. The array sends electrical signals via the optic nerve, and the brain interprets a visual image.

The FDA approval currently applies to individuals who have lost sight as a result of severe to profound retinitis pigmentosa (RP), an ailment that affects one in every 4,000 Americans. The implant allows some individuals with RP, who are completely blind, to locate objects, detect movement, improve orientation and mobility skills and discern shapes such as large letters.

The Argus II is manufactured by, and will be distributed by, Second Sight Medical Products of Sylmar, Calif., which is part of the team of scientists and engineers from the university, federal and private sectors who spent nearly two decades developing the system with public and private investment.

"Seeing my grandmother go blind motivated me to pursue ophthalmology and biomedical engineering to develop a treatment for patients for whom there was no foreseeable cure," says the technology's co-developer, Mark Humayun, associate director of research at the Doheny Eye Institute at the University of Southern California and director of the NSF Engineering Research Center for Biomimetic MicroElectronic Systems (BMES). "It was an interdisciplinary approach grounded in biomedical engineering that has allowed us to develop the Argus II, making it the first commercially approved retinal implant in the world to restore sight to some blind patients," Humayun adds.

The effort by Humayun and his
'/>"/>

Contact: Joshua A. Chamot
jchamot@nsf.gov
703-292-7730
National Science Foundation
Source:Eurekalert  

Page: 1 2 3 4 5

Related biology news :

1. Artificial womb unlocks secrets of early embryo development
2. Artificial wetlands can provide benefits over the long haul
3. UCSF artificial kidney project tapped for accelerated FDA program
4. Liquid glucagon formulation discovered for potential use in artificial pancreas systems
5. Artificial jellyfish swims in a heartbeat
6. UD partner in NIH research project to produce artificial salivary glands
7. Artificial intelligence helps detect subtle differences in mutant worms
8. Researchers develop method to grow artificial tissues with embedded nanoscale sensors
9. High-speed video and artificial flowers shed light on mysteries of hummingbird-pollinated flowers
10. New geometries: Researchers create new shapes of artificial microcompartments
11. Scale-up of a temporary bioartificial liver support system described in BioResearch Open Access
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Artificial retina receives FDA approval
(Date:9/19/2014)... of dinosaurs a newly discovered hadrosaur with ... named Rhinorex condrupus by paleontologists from ... lived in what is now Utah approximately 75 ... , Rhinorex, which translates roughly into "King Nose," ... other Cretaceous hadrosaurs like Parasaurolophus and Edmontosaurus. Hadrosaurs ...
(Date:9/19/2014)... a species which over thousands of years has adapted to ... substance that makes the cold dangerous for you. , This ... , and the cold provoking substance, called nonylphenol, comes from ... is suspected of being a endocrine disruptor, but when entering ... worm,s ability to protect the cells in its body from ...
(Date:9/18/2014)... N.Y. A sleep-promoting circuit located deep in the ... sleep. Discovered by researchers at Harvard School of Medicine ... Biomedical Sciences, this is only the second "sleep node" ... be both necessary and sufficient to produce deep sleep. ... , the study demonstrates that fully half of all ...
Breaking Biology News(10 mins):New hadrosaur noses into spotlight 2Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3No sedative necessary: Scientists discover new 'sleep node' in the brain 2
... The National Science Foundation announced this month that it ... of Illinois aimed at understanding how and whether ... support the emerging biofuels industry. The $2 million ... to institutions engaged in engineering infrastructure research. The Illinois ...
... University neuroscientists has discovered patterns of brain activity that may ... structure of objects. Computers can beat us at math ... (That,s why some Web sites use object recognition tasks as ... to us to describe a teapot as having a C-shaped ...
... pleased to inform patients that the European Committee for ... (azacitidine) a positive opinion for the treatment of myelodysplastic ... cell transplants. The CHMP,s positive opinion is ... an overall, unprecedented survival benefit for higher-risk MDS patients. ...
Cached Biology News:NSF funds research at Illinois on sustainable biofuels infrastructure 2NSF funds research at Illinois on sustainable biofuels infrastructure 3How we see objects in depth: The brain's code for 3-D structure 2How we see objects in depth: The brain's code for 3-D structure 3
(Date:9/18/2014)... , Sept. 18, 2014  Health Enhancement Products, Inc. ... investigating early-stage algae bioactive compounds and metabolic processes, is pleased ... company,s board of directors. Ms. Nola E. Masterson , ... advisor joined the board effective September 17, 2014. ... agree to join our board," states Andrew Dahl , ...
(Date:9/18/2014)... DUBLIN , Sept. 18, 2014 ... the "Global and Chinese Stem Cell Industry Report, ... Stem cells are undifferentiated biological cells that can differentiate ... produce more stem cells. Stem cell therapy can be ... of hematological system disease), nervous system diseases, damage or ...
(Date:9/18/2014)... 2014 Leatherwood Plastics has selected ... to stay competitive in the semiconductor, clean room ... ultimately impact product quality and productivity, according to ... Established in 1980 in Lewisville, TX, Leatherwood ... have left the business. Much of Leatherwood’s equipment ...
(Date:9/18/2014)... , Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. ... of previously announced concurrent but separate underwritten offerings of ... to the public of $2.00 per share, for expected ... its Series A Convertible Preferred Stock at a price ... gross proceeds of $20 million. Each share of Series ...
Breaking Biology Technology:Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3
... Join Forces to Promote Early Detection ... and Treatment of Hypertension in the UK, NEW ... (Tel Aviv Stock Exchange: INCR), and Omron Healthcare (UK),Ltd., a ... strengthen the link between hypertension diagnostics and,therapies in the professional ...
... Vical Incorporated,(Nasdaq: VICL ) today announced the ... Andrew R. de Guttadauro as Vice President, Corporate,Development. ... was Senior Director of,Strategy at Biogen Idec since ... development of that company,s Zevalin,the first radioimmunotherapy product ...
... Sales Team Forming and Increased Space, Poised for Market ... Technologies,Inc., which is developing innovative devices for the treatment ... VP of Sales, Joseph W.,Rafferty, and has started building ... first product, Pathway PV(TM) Atherectomy System. Recently Pathway ...
Cached Biology Technology:InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 2InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 3InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 4Vical Names Andrew de Guttadauro Vice President, Corporate Development 2Vical Names Andrew de Guttadauro Vice President, Corporate Development 3Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth 2
MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain...
... converts any scanner into a gel densitometer. ... features, the basic operation simply consists of ... etc.) into pixel density / intensity values ... Turn your scanner into a high ...
Mouse polyclonal antibody to QDPR - quinoid dihydropteridine reductase...
... effectively in tubes and 96 well plates. microCLEAN ... one and a half spin DNA cleanup reagent. ... concentrate any type of double stranded DNA, efficiently ... dNTPs (labelled or unlabelled). It is therefore ideally ...
Biology Products: